The enzyme UDP-glucose dehydrogenase (Udpgdh) (EC 1.1. 
Proteoglycans and hyaluronan (HA) 1 play critical roles both during embryogenesis and in the adult organism (1-3). 2 The glycosaminoglycan (GAG) side chains attached to proteoglycan core proteins share with HA a requirement for UDP-glucuronate (UDP-GlcA) in their biosynthesis. UDP-GlcA provides the D-glucuronate of HA, chondroitin sulfate, and heparan sulfate (HS) and, through C5 epimerization, the iduronate of HS and dermatan sulfate (4) . In addition to providing the glucuronate and iduronate moieties of GAGs, UDP-GlcA is the required substrate for glucuronidation of many substances, including xenobiotics, opioids, androgens and heme proteins through the action of UDP-glucuronosyl transferases in the liver (5) . UDP-GlcA is formed by the action of the NAD ϩ -linked oxidoreductase, UDP-glucose dehydrogenase (EC 1.1.1.22) on UDP-glucose. This enzyme is well characterized (reviewed in Ref. 6) , having been first identified in bovine liver in 1954 (7) and purified to homogeneity in 1969 (8) . Although this enzyme is commercially available in relatively pure form, no mammalian genes encoding UDP-glucose dehydrogenase (Udpgdh) have been identified to date.
Among UDP-glucose dehydrogenase, the most information is known regarding the bovine liver Udpgdh. This protein is proposed to act as a homohexamer of 52-kDa subunits, described as a "trimer of dimers" (9, 10) . The complete sequence of the bovine liver Udpgdh was determined in 1994 from overlapping peptides generated by proteolysis (11) . This sequence predicted a 468-amino acid protein, which shared sequence identity to other 4-electron-transferring dehydrogenases, in particular the Streptococcus pyogenes, Udpgdh, hasB (12) . Recently, three groups independently reported the identification and cloning of the Drosophila melanogaster Udpgdh gene, now formally designated sugarless (13) (14) (15) . In each case, the gene was identified through a screen of transposon-insertion mutants, the phenotype of which closely resembled that of the classical wingless (wg) mutation. These studies led to the finding that HS side chains carried on proteoglycan core proteins are required for wingless signaling. Deficiency of Udpgdh activity led to an absence of HS side chains, resulting in the observed wg phenocopy. The observed phenotype could be rescued by microinjection of Drosophila Udpgdh mRNA, UDP-glucuronate, or HS into precellular blastoderm embryos (13) . The Drosophila Udpgdh sequence shares 68% amino acid identity to the bovine sequence and 59% identity to the recently reported soybean (Glycine max) Udpgdh (16) .
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The and analysis of the vertebrate HA synthases, plasma membrane glycosyltransferases that polymerize high molecular weight HA from its activated precursors, UDP-glucuronate and UDP-N-acetylglucosamine (reviewed in Ref. 17) . It occurred to us that precursor availability may represent an additional level of regulation for HA and GAG biosynthesis. To this end, we set out to identify, clone, and characterize the gene for mouse UDP-glucose dehydrogenase. In contrast to HA synthase, which is represented by at least three family members encoded by three separate but related genes in the mouse and human (18 -21) the bovine enzyme was purified to homogeneity, we present herein the first characterization of a mammalian UDP-glucose dehydrogenase gene.
EXPERIMENTAL PROCEDURES
cDNA and Genomic Cloning-BLAST searches were performed of the human and mouse expressed sequence tag (EST) data bases using the previously deduced amino acid sequence for bovine liver Udpgdh. Candidate EST clones were used to assemble overlapping cDNA contigs to generate almost full-length cDNA sequences. A small number of EST clones were obtained from the Image Consortium, and their complete sequences were deduced by automated sequencing of both strands. Where gaps existed within contigs, synthetic oligonucleotides were generated and used to amplify cDNAs by reverse transcription polymerase chain reaction (PCR) as described previously (22) . Amplified products were gel-purified and directly cloned into pBluescript-derived T-vectors (23) for further sequence characterization. Sequence analyses were performed using BLAST searches through the National Center for Biotechnology Information site and MacVector and Genetics Computer Group software.
To determine the genomic structure for the mouse Ugdh gene, overlapping fragments encompassing the entire cDNA sequence were amplified from 129Ola genomic DNA by high fidelity long PCR as described previously (21) . Resultant PCR products were gel-purified and either directly sequenced or cloned into the pBluescript-derived Tvector for sequence and restriction site analyses. To confirm the final genomic structure of the mouse Ugdh gene, Southern analyses were performed on restriction digests of 129Ola genomic DNA using several partial cDNA probes encompassing the entire cDNA sequence. Digested DNAs were transferred to Hybond-Nϩ (Amersham Pharmacia Biotech) nylon membranes under conditions recommended by the manufacturer. Probes were labeled with [␣-32 P]dCTP by random priming (24) , and hybridization conditions were as described previously (25) .
Chromosomal Localization of the Mouse Ugdh Gene-C3H/HeJ-gld and Mus spretus (Spain) mice and ((C3H/HeJ-gld ϫ M. spretus)F 1 ϫ C3H/HeJ-gld) interspecific backcross mice were bred and maintained as described previously (26) . M. spretus was chosen as the second parent in this cross because of the relative ease of detection of informative restriction fragment length variants (RFLVs) in comparison with crosses using conventional inbred laboratory strains.
DNA isolated from mouse organs by standard techniques was digested with restriction endonucleases, and 10-g samples were electrophoresed in 0.9% agarose gels. DNA was transferred to Nytran membranes (Schleicher & Schuell, Inc.), hybridized at 65°C with probes
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labeled by random priming, and washed under stringent conditions, all as described previously (27) . Gene linkage was determined by segregation analysis (28) . Gene order was determined by analyzing all haplotypes and minimizing crossover frequency between all genes that were determined to be within a linkage group. This method resulted in determination of the most likely gene order (29).
Northern Analyses-The expression patterns for mouse and human UDP-glucose dehydrogenase were determined through hybridization of cDNA probes for the respective genes to mouse embryo and human adult multiple tissue Northern blots (CLONTECH, Palo Alto, CA). Probes were labeled by random priming as described above. Membranes were hybridized, and washes and autoradiography were performed as described previously (21) . Probes were subsequently stripped from membranes, which were rehybridized with a ␤-actin probe to control for variation in sample loading.
Expression of Mouse UDPGDH and Enzyme Assays-An expression vector for mouse UDP-glucose dehydrogenase was created through amplification of the predicted open reading frame (ORF) of approximately 1.5 kb with the following primers, 5Ј-GGCCCGGGTCATGGTTGAGAT-TAAGAAGATCTG-3Ј and 5Ј-GGCCCGGGCTAGACTT TGGGTTTCTT-GTTAGGTG-3Ј (corresponding to base pairs 108 -133 and 1592-1567, respectively; Fig. 1A ). Sites for the restriction endonuclease, SmaI, were added to 5Ј-end of each primer to facilitate subsequent cloning steps. The PCR-amplified ORF was initially cloned into the pBluescript T-vector for sequence confirmation. The insert derived from a single sequence-confirmed, PCR-derived clone was then transferred to the SmaI site of the mammalian expression vector, pCIneo (Promega).
Mouse UDP-glucose dehydrogenase pCIneo and control pCIneo (empty vector) were transfected into COS-1 cells growing in 15-cm tissue culture dishes using LipofectAMINE (Life Technologies, Inc.) under conditions recommended by the manufacturer. Crude cell lysates were prepared from transfected cells at 48 -60 h post-transfection. All procedures were carried out on wet ice. Briefly, cells were washed twice with PBS, then once with 1ϫ hypotonic lysis buffer, pH 8.7 (10 mM Tris-HCl, pH 8.7, 50 mM KCl, 1.5 mM MgCl 2 ). Cells were then allowed to swell in 12 ml of 1ϫ lysis buffer for approximately 10 min, scraped into 1 ml of lysis bufferϩ (lysis buffer supplemented with aprotinin, leupeptin, and phenylmethylsulfonyl fluoride as described previously (19) ), and transferred to a Dounce homogenizer (B-type pestle), where they were disrupted by 5-10 strokes. Nuclei and large cellular debris were pelleted at 4000 ϫ g for 10 min. Supernatants were then centrifuged at 20,000 ϫ g for 15 min, to pellet the majority of cell membranes. Protein content of the supernatant was determined through a micro-BCA assay (Pierce).
Udpgdh activities of cell lysates were assessed spectrophotometrically through measurement of the reduction of NAD ϩ in the presence of UDPglucose at 340 nm. Reactions were performed in a total volume of 1 ml (1-cm path length cuvette) with 50 g of cell lysates, or 1 ϫ 10 Ϫ3 international unit (IU) of bovine liver Udpgdh (Sigma). Reaction conditions were as follows: 1 mM UDP-glucose (Sigma), 100 mM sodium glycine, pH 8.7. Reactions were performed at room temperature (20 -23°C) and were started by addition of NAD ϩ (Sigma) to a final concentration of 1 mM. Negative control reactions also contained 1 mM UDP-xylose, a specific inhibitor of Udpgdh activity (30) . Under these conditions, 1 ϫ 10 Ϫ2 IU of bovine Udpgdh had no detectable NAD ϩ -reducing activity. Reactions were monitored for 5 min. The change in absorbance at 340 nm/min (⌬A 340 /min) was calculated and converted to IU units/mg of protein. Background NAD ϩ -reducing activity of lysates was defined as the amount of activity that remained in the presence of 1 mM UDPxylose. One IU of Udpgdh activity was defined as the activity required to reduce 2 mol of NAD ϩ /min at pH 8.7 at room temperature. Under these conditions, 1 ϫ 10 Ϫ3 IU of purified bovine Udpgdh (Sigma) had an average calculated activity of 1.27 ϫ 10 Ϫ3 IU.
Effect of IL-1␤ and Cycloheximide on Expression of UGDH by Human
Orbital Fibroblasts-Human orbital fibroblasts were obtained by culturing explants from individuals undergoing surgery for severe thyroidassociated ophthalmopathy (TAO). These activities were approved by the Institutional Review Board of the Albany Medical College. Fibroblasts were allowed to outgrow the explants and were covered with Eagle's medium supplemented with 10% fetal bovine serum, L-glutamine (2 mM), and antibiotics in a 37°C humidified incubator as described previously (31, 32) . Cultures were allowed to proliferate to confluence prior to experimental manipulation. Confluent 60-mm diameter tissue culture plates were shifted to medium containing only 1% fetal bovine serum for 16 h, followed by addition of the test compounds, IL-1␤ (10 ng/ml) (Biosource, Camarillo, CA) or the protein synthesis inhibitor cycloheximide (10 g/ml) to the culture medium. Plates were subsequently incubated for an additional 0, 3, 6, 12, or 24 h (IL-1␤) or 6 h (cycloheximide). Control plates received medium with 1% fetal bovine serum only. Total cellular RNA was prepared from culture monolayers using Ultraspec reagent (Biotecx Laboratories, Houston, TX) as recommended by the manufacturer. 20 g of each total RNA was subjected to Northern analyses using standard procedures and hybridized under high-stringency conditions to a radiolabeled human UGDH cDNA probe. After autoradiography, membranes were stripped of radioactivity and rehybridized to a glyceraldehyde-3-phosphate dehydrogenase probe to normalize for variations in sample loading. Relative expression levels of human UGDH (hUGDH) were determined by densitometry against the respective glyceraldehyde-3-phosphate dehydrogenase signals.
[ 3 H]Hyaluronan was quantitated in fibroblast cultures as described previously (32) . Briefly, confluent cultures were shifted to medium with 1% fetal bovine serum and cultured in the presence or absence of IL-1␤ (10 ng/ml) for 28 h. During the final 12 h of culture, [ 3 H]glucosamine (1 Ci/ml) was added to the culture medium. After culture, medium and solubilized cell layers were combined and treated with Pronase (Sigma, 1 mg/ml) at pH 8.0 and 50°C for 18 h. Subsequently, samples were treated with trichloroacetic acid (5% final concentration) at 4°C, centrifuged, and the acid soluble material was dialyzed extensively against cold H 2 O. Aliquots were subjected to liquid scintillation counting. Equivalent samples were treated with Streptomyces hyaluronate lyase (50 TRU/ml) as described previously (33) .
RESULTS
cDNA and Genomic Cloning-Using a combination of ESTbased cDNA clones and cDNAs generated by reverse transcription PCR, we obtained the complete sequence for the mouse and human UDP-glucose dehydrogenase cDNAs (Fig. 1A and data not shown). The two sequences predicted open reading frames of 1479 and 1482 base pairs encoding proteins of 493 and 494 amino acids, respectively. These proteins shared 98% identity to each other and 97% identity to the previously described bovine Udpgdh protein sequence (11) , except for the C-terminal 24 and 25 amino acids, which were unique to mouse and human (Fig. 1B) . Both the mouse and human cDNAs had at least two consensus polyadenylation sequences in their 3Ј-untranslated regions (Fig. 1A and data not shown) .
Through data base searches, we identified a Caenorhabditis elegans UDP-glucose dehydrogenase sequence on chromosome (Chr) III, contained within the cosmid F29F11 (GenBank TM accession number z73974). Analysis of this sequence indicated that the coding region was split into four exons spanning a total of 1.7 kb. We determined the structure of the mouse Ugdh gene. In contrast to the small size and relatively simple exon-intron structure of the C. elegans gene, the mouse Ugdh gene spans 15 kb, and the coding region is split into 10 exons (Fig. 2 and Table  I ). All exon-intron boundaries conformed to consensus splice donor and splice acceptor sequences. The location of the first intron within the mouse Ugdh gene is conserved with the C. elegans first intron, strongly suggesting that these genes are orthologous. No evidence for alternative splicing could be detected, as multiple overlapping cDNA clones predicted a single open reading frame. Southern analyses were used to confirm the gene structure and restriction map for mouse Ugdh. At high and medium stringency, all cross-hybridizing restriction fragments could be accounted for from within the Ugdh gene (data not shown), strongly suggesting that UDP-glucose dehydrogenase is encoded by a single gene in the mouse.
Chromosomal Localization Studies-To determine the chromosomal location of the Ugdh gene, we analyzed a panel of DNA samples from an interspecific cross that has been characterized for over 1200 genetic markers throughout the genome. The genetic markers included in this map span between 50 and 80 centimorgans on each mouse autosome and the X Chr (data can be accessed on the Internet at http://www.informatics.jax.org/ crossdata.html; select DNA Mapping Panel Data Sets from the Mouse Genome Database, then select "Seldin cross" and "Chromosome"). Initially, DNA from the two parental mice (C3H/HeJgld and (C3H/HeJ-gld ϫ M. spretus) F 1 ) were digested with various restriction endonucleases and hybridized with a Ugdh cDNA probe spanning exons 8 -10 to determine RFLVs to allow haplotype analyses. Informative EcoRI RFLVs were detected: C3H/HeJ-gld, 3.8 kb; M. spretus, 1.7 kb.
Comparison of the haplotype distribution of the Ugdh RFLVs indicated that this gene cosegregated in 112 of the 114 meiotic events examined with the Cncg, cyclic nucleotide gated channel, cGMP gated locus on mouse Chr 5 (Fig. 3) . The haplotype distribution among other markers localized to proximal mouse Chr 5 is shown in Fig. 3 Expression and Functional Analyses-Northern analyses indicated expression of a single mouse Ugdh transcript of 2.4 kb from gestational days 7.5-17.5, and widespread expression of human UGDH transcripts of approximately 3.4 and 2.8 kb in adult tissues (Fig. 4) . Human UGDH was most highly expressed in the adult liver and least expressed in peripheral blood leukocytes, skeletal muscle, lung, and brain. The two human UGDH transcripts are likely to represent mRNAs with alternate poly(A)-signal usage, based upon the location of consensus poly(A) signals within the 3Ј-untranslated sequence.
UDP-glucose dehydrogenase catalyzes the reaction: UDPglucose ϩ 2NAD ϩ ϩ H 2 O 3 UDP-glucuronate ϩ 2NADH ϩ 2H ϩ (34). Udpgdh activity can, therefore, be monitored spectrophotometrically through measurement of the reduction of 
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a Uppercase letters represent exonic sequence; lowercase letters represent splice donor and splice acceptor intronic sequences. Amino acids are shown below the corresponding nucleotide sequences.
b Intron sizes were approximated by restriction endonuclease digestion and agarose gel electrophoresis of polymerase chain reaction-amplified DNA fragments or determined by automated sequence analysis.
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ϩ in the presence of UDP-glucose at 340 nm. For every 1 mol of UDP-glucose converted into UDP-glucuronate, 2 mol of NAD ϩ are reduced. Thus, 1 unit of Udpgdh activity is defined as the amount of enzyme required to reduce 2 mol of NAD ϩ / min. We tested the ability of the cloned mouse Ugdh ORF to increase the detectable Udpgdh activity in mammalian cells through transfection of a mouse Ugdh expression vector into COS-1 cells. Spectrophotometric measurement indicated that Udpgdh activity of lysates prepared from these cells was elevated 5-12-fold in comparison to those prepared from vector only, mock-transfected, control cells (Table II) .
To investigate factors that may regulate the expression of UDP-glucose dehydrogenase, we utilized a model system employing the cell culture of human orbital fibroblast cells isolated from patients with TAO. This disease is associated with dramatic inflammation and disordered accumulation of HA (35) . Cytokines can enhance the synthesis of HA in these cells, although the molecular mechanisms involved have not been determined. Human UGDH transcripts of 3.4 and 2.8 kb were detectable in TAO orbital fibroblast cultures under basal (untreated) culture conditions. Treatment of confluent cultures with IL-1␤ (10 ng/ml) resulted in a time-dependent increase in the abundance of both transcripts, peaking at 6 h (Fig. 5A) . By 12 h, hUGDH transcript levels had returned to those of control (untreated) cultures. IL-1␤ treatment also increased hUGDH transcript levels in a similar fashion in cultures of human dermal fibroblasts (data not shown). Parallel experiments performed using human orbital fibroblasts indicated that IL-1␤ treatment substantially increased the incorporation of [ 3 H]glucosamine into macromolecular material (Fig. 5B) , most of which (greater than 70%) was sensitive to digestion by Streptomyces hyaluronate lyase (data not shown), defining it as HA. Addition of cycloheximide to the culture medium of human orbital fibroblasts, at a concentration that inhibits greater than 90% of protein synthesis in human fibroblasts (31) , also resulted in a 4-fold increase in hUGDH transcript levels (Fig.  5C ).
DISCUSSION
In animals, UDP-glucuronate is formed only through the action of Udpgdh on UDP-glucose. In the absence of this enzyme activity, embryogenesis fails in D. melanogaster (13) (14) (15) . Indirect evidence supports the hypothesis that lack of Udpgdh would also lead to embryonic lethality in mammals, as loss of function of a single HA synthase (which requires UDP-glucuronate as a substrate) results in embryonic lethality in the mouse. 2 The formation of UDP-glucuronate is a critical prerequisite to the biosynthesis of GAGs. Thus, defects in Udpgdh activity or expression may lead to a more general defect or reduction in GAG biosynthesis, and consequently to a defect in proteoglycan and GAG function.
Although the bovine liver Udpgdh was purified to homogeneity in 1969 (8) , no mammalian genes encoding this enzyme have been identified. To begin to investigate the molecular regulation of UDP-GlcA formation and its role in the regulation of GAG biosynthesis, we cloned cDNAs encoding mouse and human Udpgdh. The predicted protein sequences indicated high sequence conservation (97-98%) between mammalian Udpgdh proteins. The only distinctive difference between the human and mouse Udpgdh sequences and their previously described bovine counterpart (11) was the presence of an additional 25 or 24 amino acid residues, respectively, at the C terminus. Significantly, the additional amino acid residues follow a consensus cleavage site for trypsin (Fig. 1B) . It is unlikely that human and mouse Udpgdh, but not bovine Udpgdh, would share a highly conserved extended C terminus. It is more likely that the Udpgdh sequenced by Feingold and co-workers (11) was proteolytically cleaved during purification, or that the protein is naturally processed in vivo to clip off the C-terminal 24 -25 amino acids.
The mouse Ugdh gene is encoded on 10 exons, spanning 15 kilobases on mouse Chr 5, approximately 39 centimorgans from the centromere. This location strongly suggests that the human FIG. 4 . Northern analyses of UDP-glucose dehydrogenase expression in mouse and human. A, expression of Ugdh in the developing mouse embryo. A Northern blot containing mRNAs isolated from whole staged mouse embryos (CLONTECH) was sequentially hybridized with radiolabeled cDNA probes representing the ORF of mouse Ugdh and a mouse ␤-actin control probe under high stringency conditions. Autoradiography revealed a single Ugdh transcript of approximately 2.4 kb, which was present at all four developmental ages. B, expression of UGDH in human adult tissues. Multiple tissue Northern blots of human adult tissue mRNAs (CLONTECH) were sequentially hybridized with radiolabeled cDNA probes from within the human UGDH ORF and a control ␤-actin probe under high stringency conditions. Autoradiography revealed two UGDH transcripts of approximately 3.4 and 2.8 kb, which were present in most tissues, although there were large differences in relative expression levels between tissues. The highest expressing tissues were liver and prostate, and lowest expressing tissues were peripheral blood leukocytes, brain, lung, and skeletal muscle. Sk. muscle, skeletal muscle; Sm. intestine, submucosa of small intestine; PBL, peripheral blood leukocytes. Our Southern and Northern analyses strongly suggest that Udpgdh is encoded by a single gene in mouse and human. UGDH was expressed to varying degrees in all human adult tissues, with the highest levels of expression being observed in the liver, consistent with the high levels of Udpgdh activity that are present in this organ. In the mouse embryo, expression was highest at gastrulation, appeared to drop somewhat at midgestation and increased again toward late gestation.
The relative intracellular concentrations for UDP sugars have been estimated to be between 10 Ϫ4 and 10 Ϫ5 M (37, 38), similar to or lower than the K m values for the glycosyltransferases that utilize UDP sugars. It has been suggested, however, that compartmentalization of UDP sugars into the Golgi network or ER may increase their effective local concentration, such that substrates are at saturating levels for the glycosyltransferases in these compartments (39) . However, in contrast to other GAGs, HA biosynthesis occurs at the inner face of the plasma membrane (reviewed in Ref. 17) and presumably is dependent upon a cytosolic, noncompartmentalized pool of activated UDP sugar precursors. Recently, a vertebrate HA synthase, DG42 (Xenopus laevis Has1), has been calculated to possess K m values of 60 Ϯ 20 M (6 ϫ 10 Ϫ5 M) and 235 Ϯ 40 M (2.35 ϫ 10 Ϫ4 M) for its two substrates, UDP-GlcA and UDPGlcNAc, respectively (40) . At an intracellular concentration of 10
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Ϫ5 M, substrate availability may thus represent a limiting factor to HA biosynthesis. It is conceivable, therefore, that expression levels and activity of UDP-glucose dehydrogenase and consequently fluctuations in UDP-GlcA pool size may represent a means of regulating HA biosynthesis on a cellular level.
In cell culture systems, the synthesis of HA can be stimulated by a variety of growth factors and culture conditions (33, (41) (42) . These studies have indicated that HA biosynthesis can be increased in part by conditions that induce de novo protein synthesis, suggesting that increases in steady-state transcription of genes encoding enzymes within the HA biosynthetic pathway are involved. In addition, results from these studies with medium alone or with medium supplemented with IL-1␤ (10 ng/ml) for the intervals indicated along the abscissa. Total cellular RNAs were extracted from cell cultures, and Northern analyses were performed to detect hUGDH transcripts. Membranes were subsequently stripped and rehybridized with a glyceraldehyde-3-phosphate dehydrogenase probe to normalize for variations in sample loading. suggest that resident enzymes can also be activated by signaling cascades involving protein kinase C (41, 42) . Similar studies have demonstrated that intracellular pool sizes for UDPGlcA and activities of UDPGDH can be affected by exogenous factors (43, 44) . For instance, serum stimulation of quiescent Swiss 3T3 fibroblasts led to increases in UDPGDH activity that were mirrored by increases in cellular UDP-GlcA content (44) . It is likely that such increases in UDP-GlcA pool size would affect HA biosynthesis.
Human orbital fibroblasts isolated from patients with TAO or from normal orbital connective tissue synthesize large amounts of HA in culture in response to certain proinflammatory cytokines, including IL-1␤, interferon-␥, and leukoregulin (33, 45) . We used this system to begin an investigation of the impact of exogenous factors on HA biosynthesis. Based upon the results of our studies to date, it would appear that the regulation of HA biosynthesis is complex in these cells. UGDH is expressed constitutively, but transcript levels can be upregulated substantially be treatment with IL-1␤, under conditions that elicit a similar increase in [
3 H]hyaluronan biosynthesis. In addition, we have found that HAS2 mRNA can be detected by Northern analyses of confluent human orbital fibroblasts. Treatment with IL-1␤ and the T-lymphocyte cytokine, leukoregulin, can up-regulate the expression of HAS2 mRNAs in human orbital fibroblasts. 3 In preliminary studies, we have also detected low levels of human HAS1 transcripts in certain orbital fibroblasts following cytokine treatment. 3 The magnitude of the HAS2 induction, 2-3-fold in most instances, is considerably less robust than the induction of [ 3 H]hyaluronan biosynthesis by leukoregulin (up to 15-fold) (33) . Increases in HAS expression levels may not fully account for the dramatic increases in HA biosynthesis observed in orbital fibroblasts, although post-transcriptional mechanisms, such as translational efficiency of HAS2 mRNA, changes in the turnover rate of HAS2 protein, and/or activation of resident HAS2 protein may also increase the HA biosynthetic activity of the these cells. However, our current findings that hUGDH can also be up-regulated in orbital fibroblasts suggests that multiple enzymes in the HA biosynthetic pathway may represent targets for proinflammatory cytokines. Although the [ 3 H]hyaluronan measured in our experiment was determined after 28 h of culture in the presence of IL-1␤, long after UGDH transcript levels had returned to baseline levels, we realize that several steps, including translation of the UGDH mRNA, formation of the mature active UGDH enzyme complex, and UGDH-dependent conversion of UDP-glucose to UDP-GlcA, temporally separate increases in UGDH transcript levels from a potential effect on HA biosynthesis. Although we have demonstrated a correlation between increases in substrate levels and amount of product synthesized, additional studies will be required to determine the nature of this relationship.
The induction of steady-state hUGDH mRNA levels by cycloheximide suggests that this gene may be an immediate early gene. This particular finding is similar to that regarding the inflammatory cyclooxygenase, prostaglandin endoperoxide H synthase-2, in orbital fibroblasts (46) , the cycloheximide induction of which is known to parallel that of c-fos. Overall, these new insights into the impact of proinflammatory signaling pathways on GAG biosynthesis in fibroblasts may provide important clues into the molecular pathogenesis of diseases in which HA production becomes disordered, such as TAO and rheumatoid arthritis. Moreover, they may help define useful therapeutic targets.
The molecular characterization of a single gene encoding UDP-glucose dehydrogenase opens up exciting possibilities for the manipulation of GAG biosynthesis both in vitro and in vivo. Inhibition or selective removal of this enzyme activity would presumably lead to the production of "naked" proteoglycans and a lack of HA biosynthesis. Future studies will investigate the regulation of UGDH transcription by proinflammatory cytokines and growth factors and will attempt to create in vitro and in vivo models of defects in Udpgdh function.
